Our next question comes from the line of John Petrosino with JWP Incorporated. Please proceed with your question.
Good afternoon, gentlemen. I want to thank you very much for taking the time out to have this conference call. .... I also wanted to congratulate Amarantus on the outstanding milestone achievements that they have accomplished in 2013. Obviously 2013 was a very challenging year for anybody involved with the .... Things are moving in the right direction very nicely, both on the diagnostic side, as well as the therapeutic side. Congratulations to the new additions, Dr. Lowe being one, Dr. Bier being another with respect to the Board of Directors and the Board of Advisors. Dr. Simon, as well, congratulations to you.
All that said and done, my question was pretty much answered by those who were opposed by both Joseph Napotano, as well as another individual, ... All that said, a couple of things are in the back of my mind. Is there a timeframe, Gerald, that we are looking at with respect to an announcement of the second orphan indication? Is there a min/max of a time period you are looking at here on that second orphan indication?
Okay, thank you very much for that. The second question I have is with regard to the Janssen key freelancing in San Francisco. Congratulations on the move, by the way. It appears as though that is a premier location with a number of contacts and resources for Amarantus, and I’m sure that Amarantus is thrilled to be there. Can you expand upon some of the resources that are available to you there? For example, I see that Johnson & Johnson is a key backer of the facilities there. I also had noticed that J&J, the holding company, being a subsidiary of Johnson & Johnson, co-located there at the California Innovation Center. Are there any particular resources that Amarantus would be focusing on as you prepare to move to the new facilities that are at Janssen in San Francisco?
Great. Congratulations once again, and good luck to all of you gentlemen. Thank you very much for your time and efforts.
Limited vocabulary? Or falling hook, line, and sinker for a high-risk penny stock (with great potential but no revenue) and sinking every dollar he could scrape up in this risky investment? Which is it?
Congratulations... congratulations... congratulations... congratulations... and once again, congratulations!!
Has this analyst ever picked a winning stock?
